Therapeutic regimens for multiple myeloma (MM) that use a combination of the anti-CD38 monoclonal antibody daratumumab induce higher rates of sustained minimal residual disease (MRD) negativity compared with standard care, according to results from two clinical trials.
V114, a 15-valent pneumococcal vaccine, was safe and effective in children with sickle cell disease in a phase 3 trial.
Kaushik Gune, US head of Healthcare for Huma Therapeutics Limited, spoke with DocWire about Huma.AI, Huma’s generative AI platform for health care providers.
Fruquintinib combined with the anti-programmed death-1 antibody toripalimab is effective in treating advanced colon cancer.
View the latest research on heart failure for cardiologists, including updates to heart failure guidelines, treatment algorithms, clinical trials, and more.
Dr. Hady Lichaa speaks with Dr. Nyal Borges about microcatheters, and why there are essential in interventional cardiology.
Pulmonary embolism is challenging to diagnose due to its nonspecific symptoms, including abdominal pain.
Disease-modifying therapies for MS have shifted substantially since 2001, with more patients now taking oral medications.
Continuous positive airway pressure therapy improved blood pressure and preeclampsia rates in high-risk pregnancies with OSA.
The FDA converted the novel drug Leqembi, the first therapy proven to slow the course of Alzheimer disease, to full approval.
